| Feb 24, 2026 |
Feb 26, 2026 |
Ciaramella Giuseppe
|
President |
Sell |
18.8
|
-35,000
|
-15.54%
|
✓
|
$1.1M |
| Jan 31, 2026 |
Feb 2, 2026 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2026 |
Feb 2, 2026 |
Ciaramella Giuseppe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2026 |
Feb 2, 2026 |
Emany Sravan Kumar
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2026 |
Feb 2, 2026 |
Bellon Christine
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 29, 2026 |
Feb 2, 2026 |
Evans John M.
|
CEO |
Sell |
43.8
|
-50,000
|
-1.22%
|
✓
|
$1.4M |
| Jan 31, 2026 |
Feb 2, 2026 |
Simon Amy
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 22, 2026 |
Jan 26, 2026 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
21.3
|
-6,198
|
-15.11%
|
✓
|
$216.9K |
| Jan 22, 2026 |
Jan 26, 2026 |
Bellon Christine
|
Chief Legal Officer |
Sell |
48.1
|
-1,371
|
-1.41%
|
✓
|
$46.6K |
| Jan 20, 2026 |
Jan 21, 2026 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
33.8
|
-3,034
|
-6.89%
|
✓
|
$91.4K |
| Jan 15, 2026 |
Jan 20, 2026 |
Bellon Christine
|
Chief Legal Officer |
Sell |
20.0
|
-18,629
|
-16.11%
|
✓
|
$644.8K |
| Dec 31, 2025 |
Jan 5, 2026 |
Emany Sravan Kumar
|
CFO |
Sell |
30.0
|
-6,294
|
-7.87%
|
✓
|
$170.6K |
| Dec 31, 2025 |
Jan 5, 2026 |
Bellon Christine
|
Chief Legal Officer |
Sell |
48.1
|
-1,254
|
-1.07%
|
✓
|
$34K |
| Dec 31, 2025 |
Jan 5, 2026 |
Simon Amy
|
Chief Medical Officer |
Neutral |
90.0
|
+12,500
|
19.27%
|
✗
|
- |
| Oct 27, 2025 |
Oct 29, 2025 |
FMR LLC
|
10% Owner |
Sell |
51.3
|
-459
|
-0.02%
|
✗
|
$12.2K |
| Oct 6, 2025 |
Oct 8, 2025 |
FMR LLC
|
10% Owner |
Neutral |
27.5
|
-1,232,434
|
-38.35%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
48.8
|
-467
|
-1.05%
|
✓
|
$11.5K |
| Oct 1, 2025 |
Oct 3, 2025 |
Bellon Christine
|
Chief Legal Officer |
Sell |
53.8
|
-373
|
-0.32%
|
✓
|
$9.1K |
| Oct 1, 2025 |
Oct 3, 2025 |
Evans John M.
|
CEO |
Sell |
36.3
|
-50,000
|
-2.35%
|
✓
|
$1.2M |
| Jul 30, 2025 |
Aug 1, 2025 |
FMR LLC
|
10% Owner |
Sell |
20.0
|
-48,374
|
-1.48%
|
✗
|
$991.7K |
| Jul 1, 2025 |
Jul 3, 2025 |
Simon Amy
|
Chief Medical Officer |
Sell |
48.8
|
-1,250
|
-1.89%
|
✓
|
$24K |
| Jun 4, 2025 |
Jun 6, 2025 |
Walsh Kathleen E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Fishman Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Shaw Christi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Ho Carole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
MARAGANORE JOHN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 4, 2025 |
Jun 6, 2025 |
Guindo Chirfi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 10, 2025 |
FMR LLC
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
Bellon Christine
|
Chief Legal Officer |
Sell |
37.5
|
-5,674
|
-4.61%
|
✓
|
$104.1K |
| Apr 1, 2025 |
Apr 3, 2025 |
Evans John M.
|
CEO |
Sell |
38.8
|
-30,663
|
-2.74%
|
✓
|
$562.7K |
| Apr 1, 2025 |
Apr 3, 2025 |
Ciaramella Giuseppe
|
President |
Sell |
37.5
|
-7,434
|
-3.76%
|
✓
|
$136.4K |
| Apr 1, 2025 |
Apr 3, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
32.5
|
-3,015
|
-6.34%
|
✓
|
$55.3K |
| Apr 1, 2025 |
Apr 3, 2025 |
Simon Amy
|
Chief Medical Officer |
Sell |
7.5
|
-30,563
|
-31.74%
|
✓
|
$547.8K |
| Mar 31, 2025 |
Apr 2, 2025 |
Bellon Christine
|
Chief Legal Officer |
Neutral |
90.0
|
+20,000
|
19.42%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Simon Amy
|
Chief Medical Officer |
Neutral |
90.0
|
+27,500
|
39.97%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Ciaramella Giuseppe
|
President |
Neutral |
90.0
|
+35,000
|
21.52%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Neutral |
90.0
|
+10,000
|
26.65%
|
✗
|
- |
| Mar 31, 2025 |
Apr 2, 2025 |
Evans John M.
|
CEO |
Neutral |
85.0
|
+77,500
|
7.44%
|
✗
|
- |
| Jan 30, 2025 |
Apr 2, 2025 |
Evans John M.
|
CEO |
Neutral |
58.8
|
-
|
0.00%
|
✓
|
- |
| Feb 18, 2025 |
Feb 20, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
25.0
|
-6,287
|
-14.35%
|
✓
|
$220K |
| Feb 14, 2025 |
Feb 19, 2025 |
Bellon Christine
|
Chief Legal Officer |
Sell |
26.3
|
-10,000
|
-8.85%
|
✓
|
$340K |
| Jan 31, 2025 |
Feb 3, 2025 |
Bellon Christine
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2025 |
Feb 3, 2025 |
Ciaramella Giuseppe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2025 |
Feb 3, 2025 |
Simon Amy
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 30, 2025 |
Feb 3, 2025 |
Evans John M.
|
CEO |
Sell |
38.8
|
-30,000
|
-2.88%
|
✓
|
$802.5K |
| Jan 31, 2025 |
Feb 3, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2025 |
Jan 6, 2025 |
Bellon Christine
|
Chief Legal Officer |
Sell |
48.8
|
-1,241
|
-1.19%
|
✓
|
$30.6K |
| Jan 2, 2025 |
Jan 6, 2025 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
45.0
|
-1,117
|
-2.49%
|
✓
|
$27.6K |
| Dec 31, 2024 |
Jan 2, 2025 |
Emany Sravan Kumar
|
CFO |
Neutral |
90.0
|
+80,000
|
100.00%
|
✗
|
- |
| Dec 17, 2024 |
Dec 19, 2024 |
Ciaramella Giuseppe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 19, 2024 |
Emany Sravan Kumar
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 2, 2024 |
Dec 4, 2024 |
Guindo Chirfi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 4, 2024 |
Guindo Chirfi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 6, 2024 |
Nov 8, 2024 |
Ciaramella Giuseppe
|
President |
Sell |
5.0
|
-51,110
|
-31.89%
|
✓
|
$1.3M |
| Oct 14, 2024 |
Oct 16, 2024 |
Ciaramella Giuseppe
|
President |
Sell |
10.0
|
-51,110
|
-24.18%
|
✓
|
$1.3M |
| Oct 1, 2024 |
Oct 2, 2024 |
Bellon Christine
|
Chief Legal Officer |
Sell |
53.8
|
-385
|
-0.37%
|
✓
|
$9K |
| Sep 30, 2024 |
Oct 2, 2024 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Sell |
85.0
|
+2,211
|
5.18%
|
✓
|
$6.8K |
| Sep 30, 2024 |
Oct 2, 2024 |
Evans John M.
|
CEO |
Sell |
27.5
|
-60,000
|
-5.45%
|
✓
|
$1.5M |
| Aug 31, 2024 |
Sep 3, 2024 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Aug 19, 2024 |
Cavanagh Bethany J
|
SVP, Finance and Treasurer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2024 |
Jul 3, 2024 |
Simon Amy
|
Chief Medical Officer |
Sell |
48.8
|
-1,250
|
-1.78%
|
✓
|
$29.1K |
| Jun 27, 2024 |
Jun 28, 2024 |
Evans John M.
|
CEO |
Sell |
27.5
|
-60,000
|
-5.17%
|
✓
|
$1.5M |
| Jun 5, 2024 |
Jun 7, 2024 |
Shaw Christi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
MARAGANORE JOHN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Ho Carole
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Walsh Kathleen E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 5, 2024 |
Jun 7, 2024 |
Fishman Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 26, 2024 |
Apr 29, 2024 |
Burrell Terry-Ann
|
CFO |
Neutral |
90.0
|
+12,500
|
17.82%
|
✗
|
- |
| Apr 1, 2024 |
Apr 3, 2024 |
Simon Amy
|
Chief Medical Officer |
Sell |
7.5
|
-23,687
|
-25.27%
|
✓
|
$734.8K |
| Apr 1, 2024 |
Apr 3, 2024 |
Bellon Christine
|
Chief Legal Officer |
Sell |
37.5
|
-3,401
|
-3.15%
|
✓
|
$109.2K |
| Apr 1, 2024 |
Apr 3, 2024 |
Burrell Terry-Ann
|
CFO |
Sell |
32.5
|
-5,446
|
-7.21%
|
✓
|
$174.9K |
| Apr 1, 2024 |
Apr 3, 2024 |
Evans John M.
|
CEO |
Sell |
42.5
|
-18,102
|
-1.53%
|
✓
|
$581.6K |
| Apr 1, 2024 |
Apr 3, 2024 |
Ciaramella Giuseppe
|
President |
Sell |
41.3
|
-4,534
|
-2.60%
|
✓
|
$145.6K |
| Mar 31, 2024 |
Apr 2, 2024 |
Burrell Terry-Ann
|
CFO |
Neutral |
90.0
|
+27,500
|
57.19%
|
✗
|
- |
| Mar 31, 2024 |
Apr 2, 2024 |
Simon Amy
|
Chief Medical Officer |
Neutral |
90.0
|
+27,500
|
41.51%
|
✗
|
- |
| Mar 31, 2024 |
Apr 2, 2024 |
Ciaramella Giuseppe
|
President |
Neutral |
90.0
|
+35,000
|
25.15%
|
✗
|
- |
| Mar 31, 2024 |
Apr 2, 2024 |
Bellon Christine
|
Chief Legal Officer |
Neutral |
90.0
|
+27,500
|
34.16%
|
✗
|
- |
| Mar 28, 2024 |
Apr 1, 2024 |
Evans John M.
|
CEO |
Sell |
77.5
|
+17,500
|
0.81%
|
✓
|
$2M |
| Feb 13, 2024 |
Feb 15, 2024 |
FMR LLC
|
Other |
Sell |
15.0
|
-901,565
|
-18.37%
|
✗
|
$27.5M |
| Jan 31, 2024 |
Feb 2, 2024 |
Burrell Terry-Ann
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2024 |
Feb 2, 2024 |
Bellon Christine
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2024 |
Feb 2, 2024 |
Simon Amy
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 31, 2024 |
Feb 2, 2024 |
Evans John M.
|
CEO |
Sell |
32.5
|
-60,000
|
-4.91%
|
✓
|
$1.5M |
| Jan 31, 2024 |
Feb 2, 2024 |
Ciaramella Giuseppe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2024 |
Jan 5, 2024 |
Bellon Christine
|
Chief Legal Officer |
Sell |
41.3
|
-1,907
|
-2.31%
|
✓
|
$50.4K |
| Dec 22, 2023 |
Dec 27, 2023 |
FMR LLC
|
10% Owner |
Neutral |
37.5
|
-29,549
|
-0.60%
|
✗
|
- |
| Dec 13, 2023 |
Dec 14, 2023 |
Shaw Christi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Dec 14, 2023 |
Shaw Christi
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 20, 2023 |
Nov 22, 2023 |
Bellon Christine
|
Chief Legal Officer |
Sell |
22.5
|
-10,000
|
-10.82%
|
✓
|
$305K |
| Oct 30, 2023 |
Nov 1, 2023 |
Simon Amy
|
Chief Medical Officer |
Sell |
32.5
|
-3,448
|
-5.00%
|
✓
|
$64.5K |
| Oct 20, 2023 |
Oct 24, 2023 |
Ciaramella Giuseppe
|
President |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 2, 2023 |
Oct 4, 2023 |
Bellon Christine
|
Chief Legal Officer |
Sell |
53.8
|
-388
|
-0.47%
|
✓
|
$8.9K |
| Jul 10, 2023 |
Aug 9, 2023 |
Simon Amy
|
Chief Medical Officer |
Sell |
51.3
|
-391
|
-0.56%
|
✓
|
$11.9K |
| Jul 21, 2023 |
Jul 25, 2023 |
Ciaramella Giuseppe
|
President |
Sell |
3.8
|
-156,530
|
-61.86%
|
✓
|
$5M |
| Jun 6, 2023 |
Jun 8, 2023 |
Burow Kristina
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 8, 2023 |
COOPER GRAHAM K
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2033 |
Jun 8, 2023 |
Walsh Kathleen E
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 8, 2023 |
Fishman Mark
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |